Business
Eiko Lifesciences Limited Press Release Oct 31 2025
Pursuant to the Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), and amendments thereto, this is to inform that the Meeting of the Board of Directors of the Company held today i.e., on Friday, 31st October, 2025, Board, inter-alia, considered and approved Un-Audited Financial Results (Standalone & Consolidated basis) for the Quarter and Half Year ended 30th September, 2025 along with Limited Review ReportThe Meeting was commenced at 04: 45 PM and concluded at 5:30 PM.
About this update from Eiko Lifesciences Limited
Pursuant to the Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), and amendments thereto, this is to inform that the Meeting of the Board of Directors of the Company held today i.e., on Friday, 31st October, 2025, Board, inter-alia, considered and approved Un-Audited Financial Results (Standalone & Consolidated basis) for the Quarter and Half Year ended 30th September, 2025 along with Limited Review ReportThe Meeting was commenced at 04: 45 PM and concluded at 5:30 PM. View Attachment
View stock analysis, news, and events for Eiko Lifesciences Limited